We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where ...

Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

As part of the funding, Latent Labs aims to leverage generative artificial intelligence to computationally create novel ...

A new startup from one of the key scientists at Google DeepMind exits stealth today with $50 million in funding.

The molecule is also being tested in over 100 vaccine clinical trials. Rising QS-21 demand from the pharmaceutical industry ...

B.well Connected Health, maker of a platform unifying patient data, picked up an additional investment from nonprofit ...

As the technology industry continues its shift towards AI dominance, an important schism is opening up that threatens to ...

By fusing circular dichroism with high-resolution microspectroscopy and microscopic imaging, this cutting-edge technology is ...

The Middle East healthcare sector is undergoing rapid expansion presenting opportunities for ASX-listed companies. ... Read ...

Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for ...

Latent Labs hopes to take computational biology one step further. The company is developing foundation AI models that don’t ...

One of the key launch points for the modern biotechnology industry was not in the Bay Area or San Diego or Cambridge, ...